Navigation Links
UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Date:9/7/2007

isorders that make communication difficult.

We so far lack markers to identify more fundamental deficits, he said. We need to drill down and get closer to the specific level where a gene might be responsible for the process.

That is the goal of the consortium, which will target the behavioral and cognitive functions thought to underlie such neuropsychiatric syndromes as schizophrenia, bipolar disorder and attention deficit hyperactivity disorder.

In a departure from science-as-usual, the consortium will aim to discover the underpinnings of basic, healthy functioning systems such as memory and impulse control rather than concentrating on the genetic anomalies that may be associated with the neuropsychiatric disorders themselves. By focusing on these healthy brain systems, the researchers hope to accelerate the discovery of genes that are relevant to mental disorders and to find new treatments.

Employing a broad approach to attacking this problem, the consortium team comprises 52 investigators, many affiliated with the Semel Institute but cutting widely across campus disciplines as well, with members from the fields of psychiatry, neurology, neurobiology, human genetics, psychology and computer science collaborating and sharing data. Subawards will support research in Finland (at the universities of Helsinki and Oulu), at the University of California, Santa Barbara, and at the Medical University of South Carolina.

This interdisciplinary approach is a major goal of the consortium, which is one of nine nationwide being funded by the NIHs Roadmap for Medical Research program. The Roadmap program is designed not only to address health challenges that have been resistant to traditional research approaches but to fundamentally change how research is conducted, by integrating a wide range of disciplines to attack a problem. As opposed to multidisciplinary research, which involves teams of scientists approaching a problem from with
'/>"/>

Contact: Mark Wheeler
mwheeler@mednet.ucla.edu
310-794-2265
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Infant receives first bloodless liver transplant
2. Fifth US Patient Receives Artificial Heart
3. Northfield Labs Receives FDA Comments
4. British MPs Say Prostate Cancer Receives Low Priority in the NHS
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Reed Smith to Merge with Richards Butler Hong Kong 2Health News:Reed Smith to Merge with Richards Butler Hong Kong 3Health News:Reed Smith to Merge with Richards Butler Hong Kong 4Health News:The politics of the playground: lack of athletic skill often means loneliness and peer rejection 2Health News:MDS Nordion signs 17-year contract with Rosenergoatom 2Health News:UP Repeats NCQA Certification in Utilization Management 2Health News:Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock 2Health News:Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock 3Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 2Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 3Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 4Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 5Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 6Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 7Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 8Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 9Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 10Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 11Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 12Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 13Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 14
Breaking Medicine Technology:Within3 Expands into Mobile Applications 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Tim McGraw and Faith Hill Join Senior Military for Country United 3A Advancing Medicine From the Frontlines to the Homefront 47536 1Tim McGraw and Faith Hill Join Senior Military for Country United 3A Advancing Medicine From the Frontlines to the Homefront 47536 2Tim McGraw and Faith Hill Join Senior Military for Country United 3A Advancing Medicine From the Frontlines to the Homefront 47536 3New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 47533 1New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 47533 2New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 47533 3Viewers Beware Report by Watchdog Group Exposes Conservative Group Behind Anti Healthcare Ads Running in Montana 47530 1Viewers Beware Report by Watchdog Group Exposes Conservative Group Behind Anti Healthcare Ads Running in Montana 47530 2